Trial
NCT03760523
Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Minneamrita Therapeutics LLC
Condition
Acute Myeloid Leukemia
Intervention
Minnelide
Why stopped
Toxicity -Two DLT events occurred
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-07